Vertex Pharma (VRTX) CRISPR Therapeutics (CRSP) to Co-Develop and Co-Commercialize CTX001 as CRISPR … – StreetInsider.com
|
Vertex Pharma (VRTX) CRISPR Therapeutics (CRSP) to Co-Develop and Co-Commercialize CTX001 as CRISPR …
StreetInsider.com Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and CRISPR Therapeutics AG (NASDAQ: CRSP) today announced that the companies will co-develop and co-commercialize CTX001, an investigational gene editing treatment, as part of the companies' previously … Crispr Therapeutics (CRSP) Rating Reiterated by Cann |
